key: cord-0941997-ank5mmck
authors: Martínez-García, M.; Bal-Alvarado, M.; Santos Guerra, F.; Ares-Rico, R.; Suárez-Gil, R.; Rodríguez-Álvarez, A.; Pérez-López, A.; Casariego-Vales, E.; Fernández Rial, Álvaro; Rabuñal Rey, Ramón; Rodríguez Álvarez, Ana; Pérez López, Antía; Golpe Gómez, Rafael; Gil Mouce, Cristina; Suárez Ramírez, Nicolás; Almuiña Simón, Carmen; José Cereijo Quinteiro, María; Daporta Rodríguez, Luis; Fernández Valdivieso, Elvira; Vázquez Fernández, Andrés; Barcia Losada, Andrea; García Martínez, Arantza; Portero Vázquez, Amparo; Trillo Dono, Natalia; Revilla Villegas, Concepción; Fernández Rodríguez, Raquel; García Armesto, Isabel; Giadas Piñeiro, Rocío; Rosa Rodríguez Macía, Ana; Carballada González, Francisco; Núñez Orjales, Ramón; Martin Lázaro, Joaquín; Alfredo González Guzmán, Luis; Mar Abad García, María; Gloria Álvarez Silveiro, María; Carmen Coria Abel, María; Díaz Sánchez, Javier; Jesús Freire Regueiro, María; María Casanova Quiñoá, Ana; José Dobao Feijoo, María; Luisa Fernández Rodríguez, María; Rey Ponce, Ángela; Monte Secades, Rafael; Jesús Pérez Taboada, María; Sánchez Fernández, Rafael; Pérez Peña, Juan; Pereira, Manuel; Conde Freire, Jesús
title: Tracing of COVID-19 patients by telemedicine with telemonitoring
date: 2020-07-21
journal: Rev Clin Esp (Barc)
DOI: 10.1016/j.rceng.2020.07.001
sha: d83d90bf3f48158cb256b3d5c20bcf72d9b088eb
doc_id: 941997
cord_uid: ank5mmck

Abstract Aim To asses if telemedicine with telemonitoring is a clinically useful and secure tool in the tracking of patients with COVID-19. Methods A prospective observational study of patients with COVID-19 diagnosis by positive PCR considered high-risk tracked with telemedicine and telemonitoring was conducted in the sanitary area of Lugo between March 17th and April 17th, 2020. Two groups of patients were included: Outpatient Tracing from the beginning and after discharge. Every patient sent a daily clinical questionnaire with temperature and oxygen saturation 3 times a day. Proactive monitoring was done by getting in touch with every patient at least 11a day. Results 313 patients (52.4% female) with a total average age of 60.9 (DE 15.9) years were included. Additionally, 2 patients refused to join the program. Since the beginning, 224 were traced outpatient and 89 after being discharged. Among the first category, 38 (16.90%) were referred to Emergency department on 43 occasions; 18 were hospitalized (8.03%), and 2 deceased. Neither deaths nor a matter of vital emergency occurred at home. When including patients after admissions monitoring was done in 304 cases. One patient re-entered (0.32%) to the hospital, and another one left the program (0.32%). The average time of monitoring was 11.64 (SD 3.58) days, and 224 (73.68%) patients were discharged during the 30 days of study. Conclusions Our study suggests that telemedicine with home telemonitoring, used proactively, allows for monitoring high-risk patients with COVID-19 in a clinically useful and secure way.

The COVID-19 pandemic caused by SARS-CoV-2, which has progressed rapidly and has had tragic consequences, has caused a worldwide public health emergency. 1,2 The fight against this disease, whose epidemiological, clinical, and prognostic characteristics are still being studied, 3 is making it necessary to modify manners of providing care, which includes substituting some face-to-face consultations with distance consultations. 4 Telemedicine, in its different forms, has been used to diagnose, treat, or monitor patients with acute infectious diseases, such as community-acquired pneumonia; upper respiratory tract, soft tissue, or urinary tract infections; or bacterial endocarditis. 5, 6 It is believed that it can also be of use in a crisis like the current one. 4,7 However, the information currently available on the possible benefits or its safety is very limited. In recent years, the Galician Health Service has developed a tool (TELEA) that is integrated into the electronic medical record and is able to perform at-home telemedicine and telemonitoring. It allows for telematic monitoring and for anticipating possible episodes of exacerbation of a disease. Since 2015, it has been used in patients with heart failure. It has not only demonstrated its clinical utility, but has also been very well received by patients and their family members. 8 Approximately 80% of patients with COVID-19 present with a mild or moderate clinical course and habitually require treatment of symptoms. 20% of patients, especially those who are elderly or who have comorbidities, will require hospitalization due to severity criteria. 2,3 The use of telemedicine and telemonitoring would allow for the clinical evaluation of patients who present with a mild course and are isolated at home, thus avoiding exposing healthcare personnel to risks. In this study, we will evaluate the efficacy of telemedicine and telemonitoring in detecting potentially severe cases of COVID-19 among patients cared for while isolating at home.

Design. This work is a prospective observational study of patients with COVID-19 diagnosed by a positive PCR test and in at-home monitoring with telemedicine and telemonitoring. Study scope and period. The study was conducted in the Lugo healthcare area between March 17 and April 17, 2020. This healthcare area provides coverage to the 345,000 residents of Lugo and has three hospitals (Da Mariña Hospital in the north, Lucus Augusti University Hospital in the central area, and Monforte Hospital in the south). In recent years, the Galician Health Service has developed the TELEA tool, which is integrated into the electronic medical record and is able to perform at-home telemedicine and telemonitoring. With this tool, any patient who has provided the pertinent permission can send information in a pre-established format to their own electronic medical record. It is accessible to healthcare personnel from any point in the Galician healthcare network. Information can be evaluated in real-time and action can be taken in consequence. By adapting an existing model used for heart failure 8 to acute diseases, TELEA has been used for the follow-up and monitoring of patients with COVID-19 in all the Galician healthcare areas since March 3, 2020. In the Lugo healthcare area, teams of professionals were created (medical and nursing department personnel) from different departments (internal medicine, home hospitalization, allergology, rehabilitation, etc.). As nobody had previous experience in handling this tool, basic instructions were given and a detailed protocol was established, with criteria and rules for monitoring.

Participants. All patients with confirmed COVID-19 in outpatient monitoring or who were possible candidates for it were classified into groups according to their risk, with different monitoring programs established. Two groups considered to be at greater risk were selected to be included in this program:

Patients in this group communicated with the monitoring team every day of the week at 8:00 a.m.

The exclusion criteria were: 1) refusal on the part of the patient to monitoring via this method; 2) not having a smartphone, and 3) presence of clinical alarm signs in the initial interview that made it necessary to refer the patient to the Emergency Department. In figure 1 , the manner in which the process was carried out is shown graphically. When faced with a possible COVID-19 case, a physician contacts the patient via telephone, explaining the objectives, characteristics, and conditions of the monitoring. The most relevant clinical aspects are collected and, if the patient does not present with alarm signs, oral informed consent is requested. After confirmation, the physician notifies the nursing department personnel of the new enrollment. A member of this team contacts the patient to provide them with a user name and password to access the platform webpage, explaining how to enter the biomeasurements and how to answer the questionnaire. In addition, they are notified that a courier will deliver written instructions, a pulse oximeter, and a thermometer to their home that same day. The materials are collected at the end of monitoring. The nursing department team periodically reviews the information received (daily questionnaire, body temperature, and oxygen saturation three times per day) and proactively contacts all the patients via telephone, prioritizing according to the information received. As a general rule, they contact the patient at least once per day or more, if the clinical situation required it. In addition, the patient has a telephone contact number that is operational from 8:00 a.m. to 9:30 p.m. In the event of incidents (changes in biomeasurements or clinical situation as assessed by the questionnaire [table 1]), the nursing department contacts the patient and evaluates whether it is possible to solve the problem via telephone. If it is not possible, a physician will evaluate the situation and decide if it is necessary to refer him or her to the hospital emergency department. In this case, this physician is the person who contacts the department and explains the reasons why he or she advises referral. Outcomes. During the monitoring, it is considered that a patient can be discharged if they meet the following conditions: 1) at least 14 days have passed since the onset of symptoms; 2) the patient does not have symptoms or they are residual; 3) the patient has been afebrile in at least the last 72 hours, and 4) no other medical problem or complication is observed. To evaluate the results, two types of outcome measurements were used: Of the 224 patients who were monitored as outpatients from the beginning, 38 (16.90%) were referred from the emergency department; 20 (8.87%) (referred on a total of 25 occasions) were discharged after their evaluation; and 18 (8.03%) were hospitalized. It should be noted that only one patient from this group came to the Emergency Department of their own volition.

The second route of access to the program was hospital discharges ( fig. 2) . Two groups of patients were included therein: those who entered the program referred by the monitoring team and those discharged without previous contact. Of the 18 patients referred, two died and seven others continued hospitalized at the time the study ended. Therefore, of a total of 107 possible cases, monitoring was performed in 98 of them.

Outcomes. If we consider the totality of patients in the monitoring program, only two patients did not agree to be included in the study. All the others were able to connect every day and no serious problems were detected in the operation of the system.

The mean time of monitoring of the 304 patients in the study was 11.64 (SD 3.58) days and the median time of monitoring was 11 days. In the 30 days of the study, 224 (73.68%) patients were discharged from the program; one patient (0.32%) requested voluntary discharge; and one patient (0.32%) required readmission to the hospital after reactivation of COVID-19 (both in the monitoring after discharge group). At the time the study ended, 78 (25.65%) patients continued in the program (32 in monitoring since the beginning and 46 in monitoring after hospital discharge).

In figure 3 , the times of discharge are shown. 89.1% of discharges took place between days 6 and 15 of monitoring and only 4.6% of patients who started the program continued in it after 20 days. Though very few patients exited the program during the first five days, it should be noted that the two patients who later died were referred to the Emergency Department on days 1 and 3 of monitoring.

The data from this study suggest that at-home monitoring with telemedicine and telemonitoring in patients with COVID-19 is a well-accepted, useful, and safe system. Its use in higher-risk but not seriously ill patients allows for appropriate clinical monitoring, detects worsening of the disease early, helps order care at times of high demand, contributes to maintaining "social distancing" by preventing visits to emergency departments or clinics, and offers support to patients and their families.

Though telemedicine has been used in monitoring acute infectious diseases, 5,6 the majority of available evidence comes from managing patients with chronic diseases. [8] [9] [10] [11] The information available on the role that telemedicine with telemonitoring can play in the control of an epidemic is scarce. 12

In the case of COVID-19, there are various studies that provide guidelines on the work method and manner of implementing it. 13-15 Nevertheless, we believe that this is the first study that provides in-depth detail both on the technology system, the procedures for its use, and the clinical criteria for management in daily practice. One of its contributions is the definition of work strategies that have been associated with promising results. It is undoubtedly a solid foundation so that future research, which could be broader and with control groups, can define the role telemedicine should play in this or future pandemics.

The strategy that combines telemedicine and proactive monitoring has been well accepted by patients (only two did not give their consent and there was only one voluntary discharge). Contrary to what occurs in other diseases, monitoring was completed without major problems in the majority of patients. [16] [17] [18] [19] We understand that such a high degree of adherence is influenced by different factors: the ease of installation and use of the tools, the brief monitoring time (median of 11 days), and the exceptional situation of the state of alarm at the time of the study. Though many of the patients were elderly, the lockdown situation facilitated technological support from other family members who live with them.

Most likely, another reason behind adherence is that this monitoring strategy gives the user a sense of safety in uncertain times. The proactive attitude, the response to alerts, and the calls to patients within reasonable periods of time provide a feeling of surveillance and control. We understand that, at least in part, this justifies the fact that seeking out care in the hospital was uncommon.

From a clinical point of view, our data suggest that in this population, monitoring with telemedicine is clinically useful and safe. It is evident that appropriate clinical control was achieved; more severe patients were referred to the emergency department (nearly 50% were hospitalized); and, among those discharged, just one patient had symptoms of reactivation, 20 which was detected in the initial phases. All this was achieved without any situations of poor control or extreme emergency.

We understand that this system has contributed to ensuring orderly patient flows and that spontaneous visits to the emergency department have been the exception. Therefore, it is probable that it helps reduce the overloading of the system and perhaps may contribute to a lower rate of infection among healthcare personnel as well. 21 We understand that this must be linked to proactive monitoring and greater care at the times in which it is more likely that the disease would worsen. 22

Lastly, three out of every four patients were discharged in the 30 days of the study-the majority in 15 days or less-which indicates the system's agility. These data may help control patient flows and avoid overloading units. Although these results are promising, it is evident that new, multicentric, broad, controlled studies that allow for confirming these findings must be evaluated.

Nevertheless, a strategy that uses telemedicine is not free of barriers. Among them, it requires having a nationwide unified electronic medical record or procedures for action that have already been tested in other situations. Likewise, it requires a certain degree of logistical capacity, such as distributing pulse oximeters to a large number of people in a brief period of time. Furthermore, it is necessary to involve a large number of professionals to cover departments every day of the week. In this case, the marked decline in healthcare activity in the hospital made it possible to incorporate professionals from other departments, who were quickly able to adapt thanks to the simplicity of the program.

When evaluating this study, certain limitations must be taken into account. First, the data come from a single hospital center. Given that it is possible that the results are not the same in areas with different COVID-19 incidence rates, it is necessary to replicate this study in other healthcare areas. Second, doubts may arise given the absence of clinical data. However, we must consider that the aim was to evaluate the impact of the use of telemedicine with telemonitoring on the flow of patients in the system and their safety and, for these purposes, the information available is complete and rigorous. Third, the objection can be raised that a very brief period of time has been analyzed and it is not related to the clinical course of the disease. This decision was made considering that given the study's aim, it was more suitable to use, as a reference, periods of time that are related to the monitoring; easily reproducible; and restricted to the most acute phase of the disease, when the amount of care provided is greater. 

conclusion, our data suggest that at-home telemedicine with telemonitoring, used in a proactive manner, allows for clinically useful and safe monitoring of patients with COVID-19 who are high-risk yet stable at the time of diagnosis

TELEA COVID-19 Team (Lugo)

Rafael Golpe Gómez (Pulmonology Department), Cristina Gil Mouce (physician, Endocrinology Department), Nicolás Suárez Ramírez (physician, Psychiatry Department), Carmen Almuiña Simón (physician, Pediatrics-Primary Care Department). María José Cereijo Quinteiro, Luis Daporta Rodríguez, Elvira Fernández Valdivieso, Andrés Vázquez Fernández, Andrea Barcia Losada

Jesús Freire Regueiro (Nursing Department, Cardiology Department). Ana María Casanova Quiñoá, María José Dobao Feijoo, María Luisa Fernández Rodríguez